AI-generated summary
The authors report on nanocapsules carrying the anticancer drug doxorubicin (DOX) and a copper sulfide photothermal agent, tested in tumors in living animals. Under 915-nm near-infrared laser light, the authors state that tumor temperature rose from room temperature to 57 °C, and that the capsules shrank and released DOX above 42 °C. The authors describe the photothermal and drug effects as switched on by the laser and interrupted when it is turned off.
- Who or what was studied
- Tumors in vivo (animal model; species not stated in abstract)
- Wavelengths
- 915 nm
- Limits stated in the abstract
- The abstract does not report sample size, control groups, or detailed outcome measures, and the study appears to be preclinical.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on advanced.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Near-infrared, Photothermal effect. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.